Navigation Links
PDL BioPharma to Present at Two Upcoming Investor Conferences
Date:2/20/2013

INCLINE VILLAGE, Nev., Feb. 20, 2013  /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, will present at the following upcoming conferences.

RBC Capital Markets Healthcare Conference
Wednesday, February 27, 2013
9:00 a.m. ET
New York City

Cowen and Company 33rd Annual Healthcare Conference
Wednesday, March 6, 2013
9:20 a.m. ET
Boston, MA

(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)

To access the live and subsequently archived webcasts of the presentations, go to the Company's website at http://www.pdl.com and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. The archived webcast will be available for seven days following each presentation.

About PDL BioPharma

PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new revenue generating assets and maximizing value for its shareholders. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.


'/>"/>
SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
2. Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
3. Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2013
4. Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer
5. Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2013 On February 4, 2013
6. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
7. TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
8. Array BioPharma Announces Exercise And Closing Of Underwriters Over-Allotment Option
9. Gallus BioPharmaceuticals Announces Appointment of Senior Baxter Executive as Chief Commercial Officer
10. PDL BioPharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
11. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... , July 26th, 2017 /PRNewswire/ - Caprion Biosciences Inc., a world ... identifying host blood proteins predictive of early stage (latent) Mycobacterium ... and multiple reaction monitoring (MRM-MS) platform. ... Caprion Biosciences Inc. ... The new ...
(Date:7/26/2017)... ... July 25, 2017 , ... In this ... understanding of the considerations needed for designing ideal guide RNAs and DNA oligo ... to create targeted double-strand breaks in genomic DNA has greatly simplified strategies for ...
(Date:7/26/2017)... ... July 26, 2017 , ... Joni Rutter, Director of Scientific ... Health (NIH), will be one of the esteemed presenters at the 9th Annual ... multi-stakeholder discussion on the latest advancements in the precision and personalized medicine field. ...
(Date:7/25/2017)... (PRWEB) , ... July 25, ... ... pleased to welcome Chuck Heinz as Executive Director of Strategic Planning. His ... the Benchworks team. , Chuck’s professional experience encompasses marketing and differentiation consulting, ...
Breaking Biology Technology:
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017  IBM ... in dairy research, today announced a new collaboration using ... the chances that the global milk supply is impacted ... project, Cornell University has become the newest academic institution ... Chain, a food safety initiative that includes IBM Research, ...
(Date:5/16/2017)... May 16, 2017  Veratad Technologies, LLC ( www.veratad.com ... age and identity verification solutions, announced today they will ... 2017, May 15 thru May 17, 2017, in ... International Trade Center. Identity impacts the ... in today,s quickly evolving digital world, defining identity is ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
Breaking Biology News(10 mins):